NCT00346164 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 222
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 122
- group Id
- BG003
- value
- 223
- group Id
- BG004
- value
- 588
- units
- Participants
- groups
- description
- Patients with low-grade tumor with either negative or positive microscopic margins or high-grade tumor ≤ 5 cm (in maximum diameter) with negative microscopic margins are assigned to arm A: (observation only). clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery
- id
- BG000
- title
- Arm A: No Adjuvant Treatment
- description
- Patients with high-grade tumor ≤ 5 cm (in maximum diameter) with positive microscopic margins are assigned to arm B: (adjuvant radiotherapy). Beginning between 6-42 days after surgical resection, patients undergo a total of 31 fractions of adjuvant radiotherapy. clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy
- id
- BG001
- title
- Arm B: Low Risk; Adjuvant Radiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with high-grade, grossly resected primary tumor, with metastases are assigned to receive arm C: (adjuvant chemoradiotherapy). Patients receive ifosfamide IV; doxorubicin hydrochloride IV; beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- BG002
- title
- Arm C: Intermediate & High Risk; Adjuvant Chemoradiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with unresected, high-grade metastatic tumor are assigned to receive treatment as in arm D: (neoadjuvant chemoradiotherapy, surgery, and adjuvant chemotherapy with or without radiotherapy): Patients receive ifosfamide IV; doxorubicin hydrochloride IV. Beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. Patients undergo surgical resection in week 13. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- BG003
- title
- Arm D: Intermediate & High Risk; Neoadjuvant Chemoradiotherapy
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 60.88
- value
- 138.87
- group Id
- BG001
- spread
- 59.46
- value
- 142.58
- group Id
- BG002
- spread
- 69.20
- value
- 155.14
- group Id
- BG003
- spread
- 68.90
- value
- 171.31
- group Id
- BG004
- spread
- 67.10
- value
- 154.68
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 124
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 60
- group Id
- BG003
- value
- 120
- group Id
- BG004
- value
- 313
- title
- Female
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 103
- group Id
- BG004
- value
- 275
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 38
- group Id
- BG004
- value
- 90
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 185
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 95
- group Id
- BG003
- value
- 178
- group Id
- BG004
- value
- 477
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 21
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 6
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 18
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 43
- group Id
- BG004
- value
- 89
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 169
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 90
- group Id
- BG003
- value
- 137
- group Id
- BG004
- value
- 412
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 62
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 222
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 122
- group Id
- BG003
- value
- 223
- group Id
- BG004
- value
- 588
- units
- Participants
- groups
- description
- Patients with low-grade tumor with either negative or positive microscopic margins or high-grade tumor ≤ 5 cm (in maximum diameter) with negative microscopic margins are assigned to arm A: (observation only). clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery
- id
- BG000
- title
- Arm A: No Adjuvant Treatment
- description
- Patients with high-grade tumor ≤ 5 cm (in maximum diameter) with positive microscopic margins are assigned to arm B: (adjuvant radiotherapy). Beginning between 6-42 days after surgical resection, patients undergo a total of 31 fractions of adjuvant radiotherapy. clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy
- id
- BG001
- title
- Arm B: Low Risk; Adjuvant Radiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with high-grade, grossly resected primary tumor, with metastases are assigned to receive arm C: (adjuvant chemoradiotherapy). Patients receive ifosfamide IV; doxorubicin hydrochloride IV; beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- BG002
- title
- Arm C: Intermediate & High Risk; Adjuvant Chemoradiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with unresected, high-grade metastatic tumor are assigned to receive treatment as in arm D: (neoadjuvant chemoradiotherapy, surgery, and adjuvant chemotherapy with or without radiotherapy): Patients receive ifosfamide IV; doxorubicin hydrochloride IV. Beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. Patients undergo surgical resection in week 13. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- BG003
- title
- Arm D: Intermediate & High Risk; Neoadjuvant Chemoradiotherapy
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 60.88
- value
- 138.87
- group Id
- BG001
- spread
- 59.46
- value
- 142.58
- group Id
- BG002
- spread
- 69.20
- value
- 155.14
- group Id
- BG003
- spread
- 68.90
- value
- 171.31
- group Id
- BG004
- spread
- 67.10
- value
- 154.68
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 124
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 60
- group Id
- BG003
- value
- 120
- group Id
- BG004
- value
- 313
- title
- Female
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 103
- group Id
- BG004
- value
- 275
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 38
- group Id
- BG004
- value
- 90
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 185
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 95
- group Id
- BG003
- value
- 178
- group Id
- BG004
- value
- 477
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 21
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 6
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 18
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 43
- group Id
- BG004
- value
- 89
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 169
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 90
- group Id
- BG003
- value
- 137
- group Id
- BG004
- value
- 412
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 62
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle